Early-Stage trial tests new pill for untreated blood cancer
NCT ID NCT04163718
Summary
This study tested an investigational oral drug called umbralisib in patients with chronic lymphocytic leukemia (CLL) who had never received treatment before. The goal was to see how well the drug worked to control the cancer and how safe it was for patients. The trial was small and ended early, so full results are limited.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.